These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results 2005-001616-45 ESTUDIO PILOTO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL RECAMBIO PLASMÁTICO CON ALBÚMINA HUMANA 5% EN EL ACLARAMIENTO PERIFÉRICO DEL PEPTIDO BETA-AMILOIDE, Y SUS EFECTOS EN PACIENTES CON ENFERMEDAD DE... bad-data
Ongoing, reported early 2005-004830-42 "Ensayo clínico piloto, unicéntrico, controlado con placebo, a doble-ciego, aleatorio y cruzado con alfa-1-antitripsina humana en sujetos con fibromialgia". "A single-centre, randomised, double-blind... not-yet-due
Reported results 2006-002635-24 A STUDY OF IMMUNOLOGIC SAFETY FOR ALPHANATEŇ IN PREVIOUSLY TREATED PATIENTS DIAGNOSED WITH SEVERE HEMOPHILIA A 2018-12-14 due-trials
Reported results 2007-000414-36 ESTUDIO FASE II PARA VALORAR LA EFICACIA Y SEGURIDAD DEL RECAMBIO PLASMÁTICO CON ALBÚMINA 5% EN EL ACLARAMIENTO DEL PÉPTIDO BETA-AMILOIDE EN LÍQUIDO CEFALORRAQUÍDEO, Y SUS EFECTOS EN PACIENTES CON ENF... 2011-03-07 due-trials
Reported results 2008-000072-25 A Prospective, Single-blind, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis during Peripheral Vascular Surgery 2014-05-05 due-trials
Completed, but no date, and reported results 2008-002037-67 EFFICACY AND SAFETY OF FACTOR IX (FIX) CONTAINED IN ALPHANINE® AND ITS PHARMACOKINETIC COMPARISON WITH BENEFIX® IN PATIENTS WITH SEVERE HEREDITARY HAEMOPHILIA B (Follow-up study of the trial IG404: E... bad-data
Completed, but no date, and reported results 2008-003920-40 ESTUDIO CLÍNICO SOBRE LOS EFECTOS DE LA ADMINISTRACIÓN PROLONGADA DE ALBUMINA 20% SOBRE LA FUNCIÓN CARDIOCIRCULATORIA Y RENAL, Y LA HEMODINAMICA HEPATICA EN PACIENTES CON CIRROSIS AVANZADA Y ASCITIS bad-data
Completed, but no date, and reported results 2008-007313-68 A Prospective Randomized Pilot study to evaluate the effect of preoperative antithrombin supplementation on postoperative levels of antithrombin in patients undergoing cardiac surgery with cardiopulmo... bad-data
Ongoing 2009-009918-40 Ensayo Clínico fase IV, prospectivo, aleatorizado, doble ciego, de grupos paralelos y unicéntrico, para evaluar el efecto de la taurina en Nutrición Parenteral Total sobre la función hepática en pacie... not-yet-due
Exempt, with results 2009-012086-66 A Phase 1/2a, Open Label, Dose Escalation, Safety Study of Intra-thrombus Plasmin (Human) Administration in Acute, Middle Cerebral Artery, Ischemic Stroke 2014-02-10 not-yet-due
Reported results 2010-019760-36 A Phase 2, Randomized, Open-label (with Blinded Plasminogen Activator and Placebo Control Groups) Study to Evaluate the Effects of Different Intra-thrombus Infusion Regimens of Plasmin (Human) Compare... 2014-09-03 due-trials
Completed, but no date, and reported results 2010-020931-37 EFFICACY AND SAFETY OF NIULIVA FOR THE PREVENTION OF HEPATITIS B VIRUS RECURRENCE IN NEWLY ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS bad-data
Reported results 2010-021360-15 "EFECTOS DEL RECAMBIO PLASMÁTICO SOBRE LA CAPACIDAD FUNCIONAL DE LA ALBÚMINA SÉRICA, LA DISFUNCIÓN CIRCULATORIA, LA FUNCION RENAL Y CEREBRAL EN PACIENTES CIRRÓTICOS CON “ACUTE-ON-CHRONIC LIVER FAILURE... 2013-09-17 due-trials
Reported results 2011-001598-25 A multicenter, randomized, controlled study to evaluate the efficacy and safety of short-term plasma exchange followed by long-term plasmaphereses with infusion of human albumin combined with intraven... 2018-03-06 due-trials
Ongoing 2012-003450-92 EVALUATION OF THE PHARMACOKINETIC PROFILE, CLINICAL EFFICACY AND SAFETY OF THE VON WILLEBRAND FACTOR CONTAINED IN FANHDI® (DOUBLE-INACTIVATED HUMAN ANTI-HEMOPHILIC FACTOR) IN PEDIATRIC PATIENTS WITH V... not-yet-due
Listed as ongoing, but also has a completion date 2013-001870-38 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alphal-Proteinase Inhibitor (Human) in Subjec... 2017-04-04 bad-data
Exempt, with results Terminated 2013-004343-23 Studio per indagare le proprietà farmacocinetiche (per vedere quanto è attivo il farmaco di studio nel sangue e quanto tempo ci vuole per il farmaco di studio per uscire dal sangue), l'efficacia e la ... not-yet-due
Listed as ongoing, but also has a completion date 2013-004503-39 A multicenter, prospective, randomized, placebo-controlled, double-blind, parallel-group clinical trial to assess the efficacy and safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in p... 2022-11-24 bad-data
Completed, but no date, and reported results 2013-004842-40 Pilot study to evaluate the effect of plasma exchange in motor and cognitive function in patients with amyotrophic lateral sclerosis Estudio piloto sobre los efectos del recambio plasmático en la d... bad-data
Reported results 2013-005098-28 A multicenter, prospective, open-label, non-controlled clinical trial to assess the efficacy and safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in patients with Myas... 2018-04-17 due-trials
Reported results 2013-005099-17 A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/ Chromatography Purified (lGIV -C) as a Corticosteroid S... 2020-01-13 due-trials
Reported results 2013-005127-16 A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis during Peripheral Vascular Surgery 2015-12-02 due-trials
Reported results 2013-005128-40 A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Parenchymous Tissue Open Surgerie... 2015-12-28 due-trials
Reported results 2013-005159-34 A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Soft Tissue Open Surgeries 2015-06-04 due-trials
Completed, but no date, and reported results Terminated 2014-002007-13 A multicenter, randomized, placebo-controlled, double-blind and crossover pilot trial with human alpha-1 antitrypsin in patients with chronic fatigue syndrome Ensayo clínico piloto, multicéntrico,a... bad-data
Reported results 2014-003997-18 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/ Chromatography Purified (IGIV -C) in Symptomatic Subje... 2018-01-26 due-trials
Reported results 2015-003290-15 A Multi-Centre, Open-Label, Single Arm Trial to Evaluate Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency 2019-05-15 due-trials
Ongoing 2015-004110-23 An Open-Label, Multicenter Study to Evaluate the Long-term Safety of Weekly Intravenous Alpha1-Proteinase Inhibitor (Human), Modified Process 60 mg/kg in Subjects With Pulmonary Emphysema Due to Alpha... not-yet-due
Reported results 2015-005524-26 A Multicenter Phase 2 Open-Label, Single-Arm, Prospective, Interventional Study of Plasma-Derived Factor VIIII/VWF Alphanate® in Immune Tolerance Induction Therapy in Subjects with Congenital Hemophil... 2020-09-18 due-trials
Ongoing 2016-001787-10 Effects of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects with "Acute-On-Chronic Liver Failure" (ACLF) at High Risk of Hospital Efectos del recambio plasmá... not-yet-due
Ongoing 2016-001789-28 Prevention of Mortality with Long-Term Administration of Human Albumin in Subjects with Decompensated Cirrhosis and Ascites not-yet-due
Listed as ongoing, but also has a completion date and reported results 2016-004489-24 A Prospective, Randomised, Active-Controlled, Single-blind, Parallel Group Clinical Trial to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Haemostasis during... 2022-05-20 bad-data
Completed, reported early 2017-002677-19 Pathogenesis of Acute on Chronic Liver Failure (ACLF) and Mechanisms of Action of Plasma Exchange with Human Serum Albumin 5% (PE-A 5%) in Decompensated Cirrhotic Subjects with Systemic Inflammation a... 2023-03-31 not-yet-due
Not reported Terminated 2018-004005-81 A prospective, multicenter, open-label, single-arm study to evaluate the efficacy and safety of human plasma-derived fibrinogen concentrate (FIB Grifols) in subjects with congenital afibrinogenaemia a... 2023-01-12 due-trials
Reported results 2020-001696-32 A Multicenter, Randomized, Open-label Parallel Group Pilot Study to Evaluate Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) plus Standard Medical Treatment (SMT) versus SMT alone ... 2021-03-03 due-trials
Reported results 2020-001953-36 A Multicenter, Randomized, Open-label, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of Prolastin® plus Standard Medical Treatment (SMT) versus SMT alone in Hospitalized Subjects with... 2021-06-11 due-trials
Reported results Terminated 2021-000269-34 A Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of Anti-COVID-19 Immune Globulin (Human) 20% (C19-IG 20%) versus Placebo in Asymptomatic Ambulatory Ou... 2022-01-17 due-trials

Related organisations

Over time organisations can merge, or split.

We think Grifols is now also responsible for the trials of: